Purchase Order 75N93023P00673

Award Date 8/11/23
Potential Completion Date 10/11/23
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,326.00 firm fixed price purchase order to JPT Peptide Technologies GMBH, a foreign-owned, for-profit manufacturer of goods, for custom peptide synthesis. The award, which did not have any set-aside designation, supports research related to cancer, COVID-19, allergies, and infectious diseases. JPT Peptide Technologies has received...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and related research products. The $3,620 firm fixed price purchase order is for the delivery of peptide microarrays displaying peptides from a previous order, in support of NIAID's research activities. The award has no set-aside...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GmbH, a foreign-owned for-profit manufacturer of custom peptides and related products. The contract, valued at $5,497.50, is for the delivery of 40 aliquots of a Marburg glycoprotein-Musoke peptide mixture. The contract supports research related to infectious diseases and does not have a set-aside...
This federal contract award was issued by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The $4,652 firm fixed price purchase order supports the provision of peptide mixtures, reagents, assay kits, and testing services related to cancer, COVID-19, allergies, and infectious disease research. JPT has received over $250,000...
This federal contract award is for $13,930 and was made by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GMBH, a foreign-owned, for-profit manufacturer of custom peptides and peptide-based products. The contract is for the delivery of custom species-specific peptide arrays, with no set-aside designation. JPT has previously received over $250,000 in federal contract awards from NIH, USDA, and other agencies for...
The federal contract award AG7D28P150032 was issued by the Plains Area division of the U.S. Department of Health and Human Services to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The $9,758.50 firm fixed price purchase order is for the delivery of PEPSTAR PEPTIDE MICROARRAY PEPTIDES and does not have a set-aside designation. JPT Peptide Technologies has previously received over $250,000 in federal contract awards from...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $6,560 firm-fixed-price purchase order to Pepscan Presto B.V., a foreign-owned, for-profit organization, for custom peptide synthesis services. The award, which had a performance period ending on September 30, 2015, was not set aside for any specific business category. Pepscan Presto B.V. is a premier provider of peptide-based products and services with...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $28,000 firm fixed price purchase order to Karebay Biochem Inc. under request for quotes RFQ-NIAID-23-2175814. The contract calls for the delivery of a peptide library consisting of 408 peptides, each with 1 milligram of a 15 amino acid peptide at 95% purity. The place of performance is China. The award was set aside for total small business and will...
This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID Vaccine Research Center studies to better understand the immunological response and impact of vaccines on COVID-19 pathology and progression. Delivery of the peptide mixtures is to occur within three weeks of the August 11, 2023 award date at the NIAID location in Bethesda, Maryland. The award was made on a sole-source basis due to JPT being the only responsible source able to meet the agency's requirements within the necessary timeframe to avoid disrupting research continuity.

Generated 12/15/23, 4:04 AM